Share chart Pharmaron Beijing Co., Ltd.
About Pharmaron Beijing Co., Ltd.
Pharmaron Beijing Co., Ltd. вместе со своими дочерними компаниями предоставляет услуги в области фармацевтических исследований и разработок для отрасли наук о жизни в Северной Америке, Европе, материковом Китае, остальной части Азии и на международном уровне. Компания работает в пяти сегментах: Лабораторные услуги; Услуги в области химии, производства и контроля (CMC); Услуги по клиническому развитию; Биопрепараты и услуги клеточной и генной терапии; и другие. more details| ISIN | CNE100003PG4 |
|---|---|
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | hkd |
| Валюта отчета | cny |
| Див.доход ао | 5.46 |
| Дивиденд ао | 0.2199 |
| Сайт | https://www.pharmaron.com |
| Цена ао | 17.38 |
| Change price per day: | -1.14% (17.58) |
|---|---|
| Change price per week: | +14.49% (15.18) |
| Change price per month: | +5.72% (16.44) |
| Change price per 3 month: | +26.49% (13.74) |
| Change price per half year: | +56.01% (11.14) |
| Change price per year: | +70.06% (10.22) |
| Change price per 3 year: | -74.44% (68) |
| Change price per 5 year: | -67.11% (52.85) |
| Change price per 10 year: | 0% (17.38) |
| Change price per year to date: | +26.68% (13.72) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Vanguard International Stock Index-Emerging Markets Stk | 1463823 | 0.49 |
| Vanguard International Stock Index-Total Intl Stock Indx | 1425870 | 0.47 |
| DFA Emerging Markets Core Equity Portfolio | 831150 | 0.28 |
| Schwab Strategic Tr-Schwab Emerging Markets Equity ETF | 413692 | 0.14 |
| Fidelity Series Global Ex U.S. Index Fund | 317500 | 0.11 |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S. Index Fund | 313827 | 0.1 |
| DFA Emerging Markets Small Cap Series | 216700 | 0.07 |
| DFA Emerging Markets Series | 156025 | 0.05 |
| Dimensional ETF Tr-Dimensional Emerging Core Equity Market ETF | 143125 | 0.05 |
| Vanguard Intl Equity Index - Total World Stock Index Fd | 116623 | 0.04 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| First Trust Emerging Markets Small Cap AlphaDEX Fund | 0.03467 | 1061.14 | 2.70393 |
FINEX CHINA UCITS ETF
|
0.03 | -34.73 | |
| Franklin FTSE China ETF | 0.01963 | 14.5 | 3.35323 |
| Dimensional Emerging Markets Core Equity 2 ETF | 0.00694 | 15.96 | 3.34087 |
| Franklin FTSE Asia ex Japan ETF | 0.006 | 14.43 | 2.66768 |
| Dimensional World ex U.S. Core Equity 2 ETF | 0.00211 | 13.06 | 3.62488 |
SPDR S&P China ETF
|
0.00209 | 17.02 | 3.40103 |
| Avantis Emerging Markets Equity ETF | 0.00065 | 8.77 | 3.60513 |
| Avantis Responsible Emerging Markets Equity ETF | 0.00058 | 17.6 | 3.1719 |
| Vanguard ESG International Stock ETF | 0 | 6.39 | 3.07501 |
| 0.01 | 113.41 | 2.89 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Dr. Boliang Lou Ph.D. | Chairman & CEO | N/A | 1963 (62 years) |
| Ms. Bei Zheng M.A, M.A. | Executive VP & Executive Director | N/A | 1967 (58 years) |
| Mr. Shing Chung Li C.F.A., CPA | CFO & Secretary of the Board | N/A | 1978 (47 years) |
| Dr. Hua Yang Ph.D. | Chief Scientific Officer & Deputy Manager | N/A | 1962 (63 years) |
| Ms. Katherine Lee M.B.A., MBA | Chief Business Officer | N/A | |
| Mr. Xiaoqiang Lou EMBA | Co-Founder, President, COO & Executive Director | 1968 (57 years) | |
| Dr. Connie Sun Ph.D. | Senior VP & Global Head of Business Development of Small Molecules | ||
| Ms. Celina Zhong M.B.A., MBA | Senior Vice President of Human Resources | ||
| Mr. Stephen Lewinton | Senior Vice President of UK Operations | ||
| Dr. Jingqi Huang | Senior Vice President of In Vivo Pharmacology |
Address: China, Beijing, Building 1 - open in Google maps, open in Yandex maps
Website: https://www.pharmaron.com
Website: https://www.pharmaron.com
